Структурно-функциональные закономерности воздействия амфифильных блок-сополимеров на раковые клетки (1105748), страница 28
Текст из файла (страница 28)
1943 - 194880. Wolfs J. L., Comfurius P., Rasmussen J.T., Keuren J.F., Lindhout T., Zwaal R. F. et al. /Activated scramblase and inhibited aminophospholipid translocase cause phosphatidylserineexposure in a distinct platelet fraction // Cell Mol. Life Sci. ― 2005.
― V. 62. ― № 13. ―P. 1514 - 152581. Bishop W. R., Bell R. M. / Assembly of the endoplasmic reticulum phospholipid bilayer: thephosphatidylcholine transporter. // Cell. ― 1985. ― V. 42. ― № 1. ― P. 51 - 6082. Van de Berg B. M., Nieuwdorp M., Stroes E. S., Vink H. / Glycocalyx and endothelial (dys)function: from mice to men // Pharmacological Reports. ― 2006. ― V. 58. ― P. 75 - 80124 83. Албертс Б., Брей Д., Льюис Дж., Рэфф М., Робертс К., Уотсон Дж. / Молекулярнаябиология клетки // Москва, «Мир». ― 199484. Kaye S., Merry S.
/ Tumor cell resistance to anthracyclines: A review // Pharmacol. ― 1985. ―V. 14. ― № 2. ― P. 96 - 10385. Шестова О. Л., Оглоблина Т. А., Литинская Л. Л. / Роль внутриклеточного рН ввозникновении устойчивости лейкозных клеток к противоопухолевым препаратам //Эксперим. онкология. ― 1990. ― Т.12. ― № 3. ― С. 61 - 6286. Coley H. M., Amos W.
B., Twentymen T. M., Workman P. / Examination by laser scanningconfocal fluorescence imaging microscopy of the subsellular localisation of anthracyclines inparent and multidrug resistant cell lines // Br. J. Cancer. ― 1993. ― V. 67. ― № 6. ―P. 1316 - 132387. De Isabella P., Capranico G., Binaschi M., Tinelli S., and Zunino F. / Evidence of DNAtopoisomerase II-dependent mechanisms of multidrug resistance of P338 leukemia cells // Mol.Pharmacol. ― 1990.
― V. 37. ― № 1. ― P. 11 - 1688. Gollapudi S., Patel K., Jain V., and Gupta S. / Protein kinase C isoforms in multidrug resistantP338/ADR cells: a possible role in daunorubicin transport // Cancer Lett. ― 1992. ― V. 62. ―№ 1. ― P. 69 - 7589. Versantvoort C. H. M., Broxterman H. J., Feller N., Dekker H., Kuiper C. M., Lankelma J.
/Probing daunorubicin accumulation defects in non-P-glycoprotein expressing multidrug resistantcell lines using digitonin // Int. J. Cancer. ― 1992. ― V. 50. ― P. 906 - 91190. Hamada H., Tsuruo T. / Purification of the 170- to 180-kilodalton membrane glycoproteinassouciated with multidrug resistance // J. Biol. Chem. ― 1988. ― V. 263. ― № 3.
―P. 1454 - 1458.91. Deuchars K .L., Ling V. / P-glycoprotein and multidrug resistance in cancer // Chemotherapy. ―1989. ― V. 16. ― № 2. ― P. 156 - 16592. Chen C. J., Clark B., Ueda K. / Genomic organization of the human multidrug resistance (MDR1)gene and origin of P-glycoproteins // J. Biol. Chem. ― 1990. ― V. 265. ― № 1. ― P. 506 - 51493. Cornwell M. M., Tsuruo T., Gottesman M. M. / ATP-binding properties of P-glycoprotein frommultidrug-resistant KB cell // FASEB J. ― 1987.
― V. 1. ― № 1. ― P. 51 - 5494. Lum B. L., Gosland M. P., Kaubisch S., Sikic B. I. / Molecular targets in oncology: implicationsof the multidrug resistance gene // Pharmacotherapy. ― 1993. ― V. 13. ― № 2. ― P. 88 - 10995. Hsing S., Gatmaintan Z., Arias I.M. / The function of gP-170, the multidrug resistance geneproduct, in the brush border in the rat intestinal mucosa // Gastroenterology.
― 1992. ― V. 102. ―№ 3. ― P. 879 - 885125 96. Damiani D., Michieli M., Michelutti A., Geromin A., Raspadori D., Fanin R., Savignano C.,Giacca M., Pileri S.,Mallardi F. / Expression of multidrug resistance gene (MDR1) in humannormal leucocytes // Hematologica. ― 1993. ― V.
78. ― № 1. ― P. 12 - 1797. Akiama S. / Molecular basis for resistance to anticancer agents and reversal of the resistance //Human Cell. ― 1993. ― V. 6. ― № 1. ― P. 1 - 698. Damiani D., Michieli M., Michelutti A., Melli C., Cerno M., Baccarani M. / D-verapamildounmodulates P-170 associated resistance to doxorubicin, daunorubicin and idarubicin // Anticancer Drug. ― 1993. ― V. 4. ― № 2.
― P. 173 - 18099. Hinderburg A. A., Baker M. A., Gleyzer E., Stevart V. J., Case N., Taub R. N. / Effects ofverapamil and other agents on the distribution on antracyclines and of reversal of drug resistance //Cancer Research. ― 1987. ― V. 47. ― № 5. ― P. 1421 – 1425100. Page M., Alakhov V. Y. / Elimination of P-gp-mediated multi-drug resistance by solubilizationin Pluronic micelles // Proceedings of the Annual Meeting of the American Association for CancerResearch.
― 1992. ― V. 33. ― P. 552101. Alakhov V. Y., Moskaleva E. Y., Batrakova E. V., Kabanov A. V. / Hypersensitization ofmultidrag resistant human ovarian carcinoma cells by Pluronic P85 block copolymer //Bioconjugate Chem. ― 1996. ― V. 7. ― № 2. ― P. 209 - 216102.
Venne A., Li S., Mandeville R., Kabanov A. V., Alakhov V. Y. / Hypersinsensitizing effect ofPluronic® L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin inmultiple drug-resistant cells // Cancer Reseach. ― 1996. ― V. 56. ― № 16. ― P. 3626 - 3629103. Batrakova E. V., Han H. Y., Miller D. W., Kabanov A. V. / Effects of Pluronic® P85 unimersand micelles on drug permeability in polarized BBMEC and Caco-2 cells // PharmaceuticalResearch. ― 1998.
― V. 15. ― № 10. ― P. 1525 - 1532104. Batrakova E. V., Han H. Y., Alakhov V. Y., Miller D. W., Kabanov A. V. / Effects of Pluronic®block copolymers on drug absorption in Caco-2 cell monolayers // Pharmaceutical Research. ―1998. ― V. 15. ― № 6. ― P. 850 - 855105. Alakhov V. Y., Klinsky E. Y., Li S., Pietrzynski G., Venne A., Batrakova E. V., Bronich T.,Kabanov A. V. / Block copolymer-based formulation of doxorubicin.
From cell screen to clinicaltrials // Colloid and Surfaces B: Biointerfaces. ― 1999. ― V. 16. ― № 1-4. ― P. 113 - 134106. Marin A., Muniruzzaman M., Rapoport N. Y. / Mechanism of the ultrasonic activation ofmicellar drug delivery // J. Control. Release. ― 2001. ― V. 75. ― № 1-2. ― P. 69 - 81107. Rapoport N. / Combined cancer therapy by micellar-encapsulated drug and ultrasound //International Journal of Pharmaceutics. ― 2004. ― V. 277. ― № 1 – 2.
― P. 155 – 162126 108. Batrakova E. V., Dorodnych T. Y., Klinskii E. Y., Kliushnenkova E. N., Shemchukova O. V.,Goncharova O.
Y., Arjakov S. A., Alakhov V. Y., Kabanov A. V. / Anthracycline antibiotics noncovalently incorporated into the block copolymer micelles: in vivo evaluation of anti-canceractivity // Br. J. Cancer. ― 1996. ― V. 74. ― № 10. ― P. 1545 - 1552109. Kabanov A. V., Chekhonin V. P., Alakhov V. Y., Batrakova E. V., Lebedev A. S., MelikNubarov N. S. et al. / The neuroleptic activity of haloperidol increases after its solubilization insurfactant micelles. Micelles as microcontainers for drug targeting // FEBS Lett. ― 1989. ―V. 258. ― № 2. ― P. 343 - 345110.
Y.L. Lo. / Relationships between the hydrophilic-lipophilic balance values of pharmaceuticalexcipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines // J.Control. Release. ― 2003. ― V. 90. ― № 1. ― P. 37 – 48111. Batrakova E. V., Miller D. W., Li S., Alakhov V.
Y., Kabanov A. V., Elmquist W. F. / PluronicP85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies // J. Pharmaco.l Exp.Ther. ― 2001. ― V. 296. ― № 2. ― P. 551 - 557112. Buckingham L. E., Balasubramanian M., Safa A. R., Shah H., Komarov P., Emanuele R. M. etal. / Reversal of multi-drug resistance in vitro by fatty acid-PEG-fatty acid diesters // Int. J. Cancer.― 1996. ― V. 65. ― № 1. ― P.
74 - 79113. Loe D. W., Sharom F. J. / Interaction of multidrug-resistant Chinese hamster ovary cells withamphiphiles. // Br J Cancer. ― 1993. ― V. 68. ― № 2. ― P. 342 - 351114. Kabanov A. V., Batrakova E. V., Sriadibhatla S., Yang Z., Kelly D. L., Alakov V. Yu. / Polymergenomics: shifting the gene and drug delivery paradigms //J. Control. Release. ― 2005. ― V. 101.― № 1-3.
― P. 259 – 271115. Демина Т. В. /Взаимодействие амфифильных полимеров с природными и модельнымилипидными мембранами // Дисс. канд. хим. наук. 02.00.06, 03.00.04. ― М. ― 2007. ― 123 с.116. Batrakova E. V., Li S., Alakhov V. Y., Miller D. W., Kabanov A. V. / Optimal structurerequirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporteractivity in bovine brain microvessel endothelial cells // J. Pharmacol.
Exp. Ther. ― 2003. ―V. 304. ― № 2. ― P. 845 - 854117. Park E .S., Chang S. Y., Hahn M., Chi S. C. / Enhancing effect of polyoxyethylene alkyl etherson the skin permeation of ibuprofen // Int. J. Pharm. ― 2000. ― V. 209. ― № 1 - 2. ―P. 109 – 119118. Kabanov A. V., Batrakova E. V., Alakhov V. Y. / Pluronic® block copolymers for overcomingdrug resistance in cancer // Adv. Drug Del. Rev. ― 2002. ― V. 54.
― № 5. ― P. 759 – 779127 119. Wei Z., Yuan S., Hao J., Fang X. / Mechanism of inhibition of P-glycoprotein mediated effluxby Pluronic P123/F127 block copolymers: Relationship between copolymer concentration andinhibitory activity // Eur. J. Pharmaceutics and Biopharmaceutics.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
